UPC Analytics
ENDE
Analytics1Cases1Decisions0Judges3Parties0Firms
Filing trendsOutcomesPendencyTechnologyForum strategyLeading casesLegal issuesSecurity for costs

Outcome base rates

What's normal — PI grant rate, infringement rate, revocation rate, settlement rate. Honest denominators using motion type.

Legal principleProvisional measures injunction limited to the specific device at issue (GS1)Clear all
Patentee win rate
Share of merits decisions where the patentee prevailed — infringement cases finding infringement, revocation cases upholding the patent. Settled, withdrawn, and procedural-only outcomes excluded from the denominator.

No merits decisions in the current scope.

PI grant rate
100%
1 granted · 0 denied · 1 total decisions
PI grant rate (conservative)
100%
Granted / total PI decisions (incl. interim, withdrawn)
Infringement rate
—
Revocation rate
—
Settlement / withdrawal rate
Settled / withdrawn / dismissed as a share of all non-pending outcomes.
0% 0 / 1
By technology sector
Top sectors by case count (filter scope applied).
By case category
How outcome rates differ across the six L2 buckets.
  • Provisional measures1
By division
PI grant rate · infringement rate · revocation rate per division (within scope).
  • The Hague LD1 casesPI grant rate: 100%Infringement rate: —Revocation rate: —
Recent decisions
Most recent decisions in scope.
  • 2024-06-19ACT_14944/2024PI grantedThe Local Division The Hague granted Abbott Diabetes Care a preliminary injunction against Sibio Technology and Umedwings for infringement of a patent relating to a continuous glucose monitoring device (GS1), finding all conditions under R.211 RoP met and the balance of interests in Abbott's favour, as defendants had left the relevant markets.